Diversion Control Division, US Department of Justice, Drug Enforcement Administration

Manufacturers Notice of Registration - 2007

FR Doc E7-9631 [Federal Register: May 18, 2007 (Volume 72, Number 96)] [Notices] [Page 28075-28076] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr18my07-101]


DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Registration

By Notice dated August 15, 2006, and published in the Federal Register on August 22, 2006, (71 FR 48947), Noramco Inc., Division of Ortho-McNeil, Inc., 500 Old Swedes Landing Road, Wilmington, Delaware 19801, made application by renewal, and by separate correspondence dated June 2,

[[Page 28076]]

2006, and July 25, 2006, to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule I and II:

Drug  Schedule 
Codeine-N-Oxide (9053)  I
Morphine-N-Oxide (9307)  I
Codeine (9050) II
Dihydrocodeine (9120)  II
Oxycodone (9143)  II
Dihydromorphine (9145)  II
Hydrocodone (9193)  II
Thebaine (9333)  II
Morphine (9300)  II
Oxymorphone (9652)  II

The company plans to bulk manufacture the above listed controlled substances for sale and distribution to manufacturers for product development and formulation. 

By letter dated January 4, 2007, Noramco has withdrawn their request for Amphetamine (1100) and Methylphenidate (1724). 

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Noramco Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Noramco Inc. to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with State and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33(a), the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed.

Dated: May 8, 2007. 

Joseph T. Rannazzisi, 
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. 

[FR Doc. E7-9631 Filed 5-17-07; 8:45 am]

BILLING CODE 4410-09-P

 

NOTICE: This is an unofficial version. An official version of this publication may be obtained directly from the Government Printing Office (GPO).

Emergency Disaster Relief
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

U.S. DEPARTMENT OF JUSTICE  •  DRUG ENFORCEMENT ADMINISTRATION
Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility